SCHEMBL8687249

SCHEMBL8687249

O=C1SC(=Cc2c[nH]c3ccccc23)C(=O)N1Cc1ccc(C(F)(F)F)cc1C(F)(F)F

nearest known ligand 0.52

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
▸ ESRRA P11474 2/20 0.45
▸ PIM1 P11309 1/20 0.42
▸ PTGS2 P35354 1/20 0.41
▸ NLRP3 Q96P20 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8689406 0.89 PIM1 (0.44) PIM1
SCHEMBL8688100 0.88 ESRRA (0.44) ESRRAPIM1NLRP3
SCHEMBL8687825 0.85 PIM1 (0.49) PIM1PTGS2NLRP3
SCHEMBL6235055 0.74 MEN1 (0.56) —
SCHEMBL6235054 0.74 MEN1 (0.56) —
SCHEMBL5470545 0.74 PTPN1 (0.48) —
SCHEMBL5470542 0.74 PTPN1 (0.48) —
SCHEMBL8689993 0.72 NLRP3 (0.49) PIM1NLRP3
SCHEMBL8687698 0.71 TACR1 (0.49) —
SCHEMBL13780771 0.69 MMP1 (0.54) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5811439-A ANTIDIABETIC AGENTS; SIDE EFFECT REDUCTION; ANTILEPEMIC AGENTS SENGA PHARMACEUTICAL LABORATORY INC. (JP) 1998-09-22 — — US disclosed
Send feedback